Obesity management is evolving beyond weight reduction alone as healthcare systems increasingly recognize obesity as a chronic disease requiring long-term management. With overweight and obesity contributing to the rising burden of type 2 diabetes, cardiovascular disease, fatty liver disease, and other metabolic disorders, the focus is shifting from reactive treatment to proactive, comprehensive disease management.
Ajanta Pharma has identified five key trends that are expected to shape the future of obesity care in India over the coming years.
1. Obesity will be increasingly treated as a chronic disease
The company said obesity is increasingly being recognized by medical experts as a chronic disease influenced by genetic, physiological, environmental, behavioural, and lifestyle factors, a shift that is expected to drive more structured and evidence-based treatment approaches.
2. Earlier intervention will become more common
Traditionally, obesity treatment has often begun only after related complications developed. Going forward, the company expects healthcare professionals to increasingly adopt earlier intervention strategies to reduce long-term health risks and improve patient outcomes.
3. Digital patient support will become a critical part of treatment
The company said successful obesity management depends not only on clinical intervention but also on patient adherence, education and continuous support. As a result, digital health platforms, teleconsultations, patient education tools, medication reminders, and lifestyle coaching are likely to play an increasingly important role in obesity management.
4. Personalized nutrition and lifestyle programmes will gain importance
The company also anticipates personalized obesity care to gain momentum through individualized treatment plans that combine medical therapy with tailored nutrition, physical activity, and behavioural support. It added that the future of obesity management will rely on multidisciplinary collaboration among physicians, dietitians, fitness professionals and patient support teams.
5. Integrated metabolic health will replace weight-loss-only conversations
The company said the focus of obesity management is increasingly shifting beyond weight loss to broader health outcomes, including better glycemic control, reduced cardiovascular risk, improved quality of life, and long-term metabolic health. “This evolution reflects a growing understanding that successful obesity management is about improving overall health, not simply reducing body weight,” it noted.
To support this evolving landscape, Ajanta Pharma has expanded its obesity management portfolio with Ozanta, a semaglutide-based therapy, while investing in patient support programmes, expert-led education initiatives, and digital engagement platforms to improve treatment adherence and long-term outcomes.
Pourus Vakil, President – India Business, Ajanta Pharma, said, “The future of obesity management will be defined not only by scientific advancements but by how effectively we support patients throughout their journey. Building awareness, improving access to information, and strengthening patient engagement will be critical to long-term success.”
Effective obesity care is expected to play a key role in cardiometabolic risk management by helping prevent diabetes, improving cardiovascular health, reducing obesity-related complications, and supporting long-term metabolic well-being.
